Cite
Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review
MLA
Xiao-Wu Huang, et al. “Sorafenib in Treatment of Patients with Advanced Hepatocellular Carcinoma: A Systematic Review.” Hepatobiliarypancreatic Diseases International : HBPD INT, vol. 11, no. 5, Oct. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....51b1fa89c256e467807409ac575d4417&authtype=sso&custid=ns315887.
APA
Xiao-Wu Huang, Zheng Wang, Jian Zhou, Xin Zhang, Yang Xu, Wei-Min Wang, Ruo-Yu Shi, Shuang-Jian Qiu, Jia Fan, & Xin-Rong Yang. (2012). Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review. Hepatobiliarypancreatic Diseases International : HBPD INT, 11(5).
Chicago
Xiao-Wu Huang, Zheng Wang, Jian Zhou, Xin Zhang, Yang Xu, Wei-Min Wang, Ruo-Yu Shi, Shuang-Jian Qiu, Jia Fan, and Xin-Rong Yang. 2012. “Sorafenib in Treatment of Patients with Advanced Hepatocellular Carcinoma: A Systematic Review.” Hepatobiliarypancreatic Diseases International : HBPD INT 11 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....51b1fa89c256e467807409ac575d4417&authtype=sso&custid=ns315887.